Reach Us +1-218-451-2974


Andreas Schulze | OMICS International
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Andreas Schulze

Andreas Schulze Genetics and Genome Biology University of Toronto Canada


Dr. Andreas Schulze is a Director, Newborn Screening Program Clinical and Metabolic Genetics and Associate Scientist in Department of Genetics & Genome Biology at University of Toronto his Research Interests Genetic Diseases of Creatine Metabolism. Improving strategies for early diagnosis and treatment in genetic defects of guanidinoacetate methyltransferase (GAMT), arginine: glycine amidinotransferase (AGAT) and creatine transporter (CrT1). My research suggests that early and efficient treatment may prevent severe neurological impairment in patients. My research goal is to develop comprehensive biochemical and molecular genetic testing and inclusion in newborn screening. Through my research I plan to optimize existing, and develop new treatments to improve brain creatine uptake and to reduce neurotoxic guanidinoacetate. I will also continue to study AGAT and GAMT knock-out mice and development of a model for the CRT defect.


Global Speakers in the subject

Global Experts in the subject